NatWest Group’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

NatWest Group’s Portfolio CBST Stock Details CBST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-8,849	Closed	-$891	–	469
2014 Q4	$891	Buy	+8,849	New	+$688K	0.01%	228
2013 Q4	–	Sell	-9,273	Closed	-$589K	–	997
2013 Q3	$589K	Buy	+9,273	New	+$560K	0.02%	642

NatWest Group's CBST Position: Q1 2015 in Review

NatWest Group sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 8,849 shares — an estimated $891 sold.

NatWest Group first reported a position in CBST in Q3 2013 and held it in 2 quarters. The position peaked at $589K in Q3 2013. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

NatWest Group reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
NatWest Group sold 8,849 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $891.
NatWest Group first reported a position in CUBIST PHARMACEUTICALS INC in Q3 2013 and held it in 2 quarters.
NatWest Group's CUBIST PHARMACEUTICALS INC position peaked at $589K in Q3 2013.
0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on NatWest Group's 13F filing for Q1 2015, filed 14 May 2015.